Eurofins reports renewed buybacks, shares trade near 68 euros
30.06.2026 - 14:18:01 | ad-hoc-news.deBy Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-30, 14:17.
Eurofins Scientific SE (FR0014000MR3) stays in the market's view in Paris after a fresh weekly repurchase report. The company said it bought back 130,000 shares between June 22 and June 26, 2026, according to a disclosure republished by StreetInsider. StreetInsider on the weekly buyback report
What the buyback filing shows
The report lists purchases on six trading days and gives weighted average prices ranging from 62.7228 to 68.4282 euros. The total repurchased volume reached 130,000 shares, with the strongest single-day volume shown on June 25 and June 26.
The latest print on MarketScreener put Eurofins Scientific SE at 68.18 euros on June 29, 2026, down 1.13 percent on the day. The same page also shows a year-to-date gain of 9.26 percent for the Euronext Paris listing. MarketScreener price page
Paris listing in view
Euronext Paris remains the central venue for the Eurofins shares, which trade in euros. That local anchor matters because it ties the repurchase disclosures directly to the primary listing and to the price history shown for late June.
All news and analysis on the Eurofins shares
The June buyback filing and the Paris quote history sit together in one place for readers tracking Eurofins in Euronext trade.
What Eurofins sells
Eurofins runs laboratory testing services across food, environmental, pharmaceutical, and consumer product markets. Its portfolio also covers diagnostic and analytical work for regulated industries, which gives the group a broad recurring-revenue base.
Eurofins shares today
The Eurofins shares (FR0014000MR3) trade on 2026-06-29, 16:55 on Euronext Paris at 68.18 euros.
Key data on the Eurofins shares
- Company: Eurofins Scientific SE
- ISIN: FR0014000MR3
- Ticker: ERF
- Trading venue: Euronext Paris
- Price (as of 2026-06-29, 16:55): 68.18 euros
- Market cap: 12.43 billion euros (as of 2026-06-29)
- Sector / industry: Health Care - Life Sciences Tools and Services
- Index membership: Stoxx Europe 600
Disclaimer: This article is for information only and does not constitute investment advice.
